ULK1: a promising biomarker in predicting poor prognosis and therapeutic response in human nasopharygeal carcinoma.
Plenty of studies have established that dysregulation of autophagy plays an essential role in cancer progression. The autophagy-related proteins have been reported to be closely associated with human cancer patients' prognosis. We explored the expression dynamics and prognostic value of autopha...
Autors principals: | Miao Yun, Hai-Yan Bai, Jia-Xing Zhang, Jian Rong, Hui-Wen Weng, Zhou-San Zheng, Yi Xu, Zhu-Ting Tong, Xiao-Xia Huang, Yi-Ji Liao, Shi-Juan Mai, Sheng Ye, Dan Xie |
---|---|
Format: | Article |
Idioma: | English |
Publicat: |
Public Library of Science (PLoS)
2015-01-01
|
Col·lecció: | PLoS ONE |
Accés en línia: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0117375&type=printable |
Ítems similars
-
High number of granzyme B expressing CTLs predicts worst prognosis of nasopharygeal carcinoma patients
per: Perpustakaan UGM, i-lib
Publicat: (2008) -
The Failure Patterns of Nasopharygeal Carcinoma After Intensity-Modulated Radiotherapy and Implications for Surveillance
per: Tian Y, et al.
Publicat: (2022-10-01) -
Cloning and expression of epstein-barr viral antigens for the diagnosis of nasopharygeal carcinoma
per: He, Yan Xin.
Publicat: (2009) -
ULK1 as a novel therapeutic target in neurodegeneration
per: Björn Friedhelm Vahsen, et al.
Publicat: (2021-01-01) -
The incredible ULKs
per: Alers Sebastian, et al.
Publicat: (2012-03-01)